Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00939
Species: Homo sapiens
Position : chr8:129543949-129554294
Year: 2016
Title: Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: endometrial carcinoma
PMID:  26656844
MONDO: MONDO:0002447
Tissue: uterus
Tissue Ontology ID: UBERON:0000995
Cell Source: Endometrial Carcinoma Cell Lines Ishikawa
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Endogenous enhancer perturbation; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase reporter assay; Reporter assay; CRISPR-Cas9 targeted editing/deletion; ChIP-qPCR/ChIP; 3C; RT-qPCR/qPCR; RNAi/siRNA/shRNA
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00976 chr8:129543949-129554294 endometrium malignant cell endometrial carcinoma
E_00977 chr8:129543949-129554294 endometrium epithelial cell endometrial carcinoma
E_05249 chr8:129546728-129712179 blood B-lymphoblast/precursor B cell B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer